SG Americas Securities’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,597
| Closed | -$74K | – | 2661 |
|
|
2024
Q3 | $74K | Buy |
+10,597
| New | +$74K | ﹤0.01% | 2796 |
|
|
2022
Q2 | – | Sell |
-1,257
| Closed | -$16K | – | 3030 |
|
|
2022
Q1 | $16K | Sell |
1,257
-1,192
| -49% | -$15.2K | ﹤0.01% | 2534 |
|
|
2021
Q4 | $43K | Sell |
2,449
-4,444
| -64% | -$78K | ﹤0.01% | 2879 |
|
|
2021
Q3 | $150K | Buy |
+6,893
| New | +$150K | ﹤0.01% | 3165 |
|
|
2021
Q2 | – | Sell |
-2,059
| Closed | -$203K | – | 2479 |
|
|
2021
Q1 | $203K | Buy |
2,059
+549
| +36% | +$54.1K | ﹤0.01% | 2435 |
|
|
2020
Q4 | $164K | Sell |
1,510
-8,315
| -85% | -$903K | ﹤0.01% | 2414 |
|
|
2020
Q3 | $1.01M | Buy |
9,825
+8,660
| +743% | +$892K | 0.01% | 961 |
|
|
2020
Q2 | $243K | Sell |
1,165
-3,774
| -76% | -$787K | ﹤0.01% | 2318 |
|
|
2020
Q1 | $483K | Buy |
+4,939
| New | +$483K | ﹤0.01% | 1537 |
|
|
2019
Q4 | – | Sell |
-3,754
| Closed | -$205K | – | 2665 |
|
|
2019
Q3 | $205K | Buy |
+3,754
| New | +$205K | ﹤0.01% | 2001 |
|
|
2019
Q2 | – | Sell |
-1,136
| Closed | -$60K | – | 2514 |
|
|
2019
Q1 | $60K | Buy |
+1,136
| New | +$60K | ﹤0.01% | 2735 |
|
|
2018
Q3 | – | Sell |
-1,078
| Closed | -$57K | – | 2546 |
|
|
2018
Q2 | $57K | Buy |
+1,078
| New | +$57K | ﹤0.01% | 2720 |
|
|
2015
Q1 | – | Sell |
-426
| Closed | -$230K | – | 2082 |
|
|
2014
Q4 | $230K | Buy |
+426
| New | +$230K | ﹤0.01% | 2052 |
|